Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Genomic Health, Inc.    GHDX

Delayed Quote. Delayed  - 07/25 07:30:15 pm
27.735 USD   -1.65%
07/12 GENOMIC HEALTH : to Offer Epic Science's AR-V7 test, Shares Up
07/07 GENOMIC HEALTH : and Epic Sciences Announce Strategic Collaboration ..
06/20 GENOMIC HEALTH : Updated NICE quality standard recommends Oncotype D..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/19/2016 07/20/2016 07/21/2016 07/22/2016 07/25/2016 Date
27.27(c) 27.92(c) 28.87(c) 28.2(c) 27.735 Last
134 251 265 662 145 311 70 228 25 512 Volume
-0.33% +2.38% +3.40% -2.32% -1.65% Change
More quotes
Financials ($)
Sales 2016 330 M
EBIT 2016 -17,6 M
Net income 2016 -11,9 M
Debt 2016 6,77 M
Yield 2016 1,40%
Sales 2017 368 M
EBIT 2017 4,64 M
Net income 2017 2,75 M
Debt 2017 28,3 M
Yield 2017 1,42%
P/E ratio 2016 -
P/E ratio 2017 252,91
EV / Sales2016 2,84x
EV / Sales2017 2,61x
Capitalization 931 M
More Financials
Company
Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions.The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in... 
More about the company
Surperformance© ratings of Genomic Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMIC HEALTH, INC.
07/15 GENOMIC HEALTH : and Epic Sciences Announce Strategic Collaboration to Deliver N..
07/12 GENOMIC HEALTH : to Offer Epic Science's AR-V7 test, Shares Up
07/07 GENOMIC HEALTH : and Epic Sciences Announce Strategic Collaboration to Deliver N..
06/23 GENOMIC HEALTH INC : Change in Directors or Principal Officers (form 8-K)
06/20 GENOMIC HEALTH : Updated NICE quality standard recommends Oncotype DX® in early-..
06/16 GENOMIC HEALTH : Nature Partner Journals Publish Five-year Outcomes Results from..
06/16 GENOMIC HEALTH : Announces Multiple Oncotype DX® Presentations at ASCO 2016 Show..
06/15 GENOMIC HEALTH INC : Submission of Matters to a Vote of Security Holders (form 8..
06/14 GENOMIC HEALTH : Launches Oncotype SEQ(TM) Liquid Biopsy Mutation Panel
06/02 GENOMIC HEALTH : Announces Publication in Journal of Clinical Oncology Demonstra..
More news
Sector news : Biotechnology & Medical Research - NEC
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/12DJAmgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12DJJuno to Resume Clinical Trial of Anticancer Treatment
07/09DJCorrections & Amplifications -- WSJ
07/08DJAMGEN : Theranos Dealt Blow as Holmes Is Banned From -2-
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
07/07 Genomic Health inks deal with Epic Sciences to commercialize liquid biopsy te..
05/04 Genomic Health's (GHDX) CEO Kimberly Popovits Q1 2016 Results - Earnings Call..
05/04 Genomic Health beats by $0.05, beats on revenue
05/03 Notable earnings after Wednesday?s close
05/03 The Biggest Microcap In My Biotech Portfolio With Fuel For Growth
Advertisement
Chart GENOMIC HEALTH, INC.
Duration : Period :
Genomic Health, Inc. Technical Analysis Chart | GHDX | US37244C1018 | 4-Traders
Full-screen chart
Technical analysis trends GENOMIC HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 31,4 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kimberly J. Popovits Chairman, President & Chief Executive Officer
G. Bradley Cole Chief Operating & Financial Officer
Steven Shak Chief Scientific Officer
Paul Aldridge Chief Information Officer & Senior Vice President
Phillip G. Febbo Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GENOMIC HEALTH, INC.-19.89%931
INCYTE CORPORATION-20.32%16 212
CELLTRION, INC.--.--%10 689
LONZA GROUP AG11.40%9 737
QUINTILES TRANSNATIONA..7.82%8 859
ALKERMES PLC-37.26%7 528
More Results